EU Leaders Reach Agreement On Unitary Patent System
Posted: 06/29/2012 12:00:00 AM EDT | 0
|
- Comment from intellectual property specialists Marks & Clerk LLP –
Leaders of European Union states reached agreement today on a unitary patent system at a summit, settling on a compromise to share the location of the court between Paris, London, and Munich.
Keith Hodkinson, Partner and Chairman of Marks & Clerk International, comments:
“Today’s agreement does not in fact represent a final agreement on the Unitary Patent Court or a victory for the UK Government.
“Whilst the location the court is certainly of economic significance, and the decision to locate at least certain specialist work in London is of course welcome, the chief concern for the professions and industry has always been the fundamental flaws in the regime, rather than the issue of where cases are heard.
"Specifically, we have consistently opposed the provisions in articles six to eight governing the role of the European Court of Justice, a point evidently taken up by the UK Government in the horse trading which has gone on over the past few hours.
“Today’s agreement from the Council of Ministers "suggests" that these articles be deleted – indeed, this was the whole point of Cameron’s veto threat. But it is not at all clear that the Council of Ministers can insist on this or that the Commission will agree or what, if anything, would take the place of the deleted articles. It is quite possible that the UK has signed up to a blank cheque, or the very regime it was threatening to veto not more than a few hours ago.
"It is also unclear what will happen to the issue of bifurcation (splitting infringement and invalidity issues into separate proceedings).
“We would have preferred clarity on these fundamental practical issues in the regime before committing the UK to it. Better to allow a few months to rewrite the articles than to go into a new regime blind.
“So, despite talk of final agreement there are a number of pressing questions yet to be answered, and this process could yet continue for some time.”
|
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
-
Optimising the Development of Protein Formulations -
The Top 10 Pharma Drug Recalls: Time for Innovation -
Data Management at McLaren Racing -
Regulatory Guidelines for Viral Safety -
Do Pharma Organisations do enough to encourage the e-patient? -
The Top 10 Biggest Pharmaceutical Companies: Who's Recruiting? -
Asia Focus: Top 5 Challenges around Pharmacovigilance -
Pharma IQ Reviews Innovation at the Top 10 Global Drug Companies Over the Last 15 Years -
What Agile Software Development Learned From Deming -
Molecule in the Image of Olympic Rings
* = required.
-
Electronic Laboratory Notebooks Online
December 2, 2011
Register Now -
Guarantee GDP- Compliant Cool Chain Logistics for Pharmaceuticals to CEE & CIS Countries
January 16, 2013
Register Now -
EU Product Launch – Key Considerations for Successful Niche and Orphan Drug Product Launches
February 9, 2012
Register Now -
First-Inventor-to-file: Protect Your Research Data
May 23, 2012
Register Now




Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!